KLONA BIOTECH
LIVE

Serial Number

99677708

Owner

Klona Biotech Inc.

Attorney

Connie L. Ellerbach

Filing Date

Mar 2, 2026

Add to watchlist:

No watchlists yet
View on USPTO

KLONA BIOTECH Trademark

Serial Number: 99677708

KLONA BIOTECH is a trademark filed by Klona Biotech Inc. on March 2, 2026. The trademark is classified under Class 1 (Chemicals), Class 2 (Paints), Class 5 (Pharmaceuticals), Class 7 (Machinery), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Klona Biotech Inc.

251 Little Falls Drive
New Castle County, DE 19808

Entity Type: 03

Trademark Details

Filing Date

March 2, 2026

Registration Date

Not Registered

Goods & Services

Custom manufacturing of biological tissues and tissue constructs for others using three-dimensional (3D) bioprinting; custom contract 3D bioprinting services for the production of biological materials and engineered tissues for others; custom fabrication of biomaterial scaffolds for third parties; custom additive manufacturing services in the field of biofabrication, for others; custom manufacture of hydrogel and polymer biological structures for research and medical applications; bioprinting services, namely, fabrication of biological constructs in the nature of bioprinted medical implants to order for others

Scientific research and development in the field of three-dimensional (3D) bioprinting and biofabrication; scientific and technological services, namely, research and design of bioinks and biomaterials; product development in the field of tissue engineering and regenerative medicine; laboratory research services relating to engineered tissues and biological structures; design and testing of new products, namely, bioprinting materials, for others; biomedical research services; engineering and technical consulting services in the field of biological printing systems; development of quality control standards for custom biofabrication and printing for others

Bioinks comprised primarily of biological materials for medical use; biological preparations for tissue engineering for medical purposes; engineered biological tissue cultures for regenerative medicine for medical purposes; living tissue constructs for medical use; implantable biological scaffolds comprising living tissue for maintaining tissue contour for medical use; biomaterial matrices for medical use for tissue repair and regeneration; sterile biofabricated tissues for surgical implantation; regenerative medicine products, namely, engineered biological tissue grafts

Ink cartridges, filled, specially adapted for medical bioprinters

Three-dimensional (3D) bioprinters for medical use; printer heads and cartridges specially adapted for 3D medical bioprinters; 3D bioprinters in the nature of tissue printing machines for medical applications; 3D printers containing sterile printing chambers for medical bioprinting

Medical devices in the nature of tissue bioprinting systems for printing biological tissues and cellular structures; biofabrication apparatus in the nature of bioprinting instruments for creating living tissues for medical purposes; medical instruments for dispensing and depositing bioinks and biomaterials; sterile printing chambers for medical bioprinting; tissue printing machines for medical applications; structural parts and fittings for the aforesaid medical apparatus

Downloadable software for controlling and operating three-dimensional (3D) bioprinters and biofabrication systems; downloadable software for designing and modeling biological structures for printing; downloadable software for processing and preparing biofabrication print files; downloadable software for monitoring and controlling biofabrication processes; downloadable computer software platforms for managing biological printing workflows; recorded operating software, capable of functioning offline, for slicing and controlling bioprinting apparatus

Biological and chemical compositions in the nature of biological and chemical preparations for use in scientific and laboratory research; polymer-based and hydrogel-based compositions for use in the manufacture of commercial, industrial and domestic goods for three-dimensional (3D) bioprinting for scientific use; unprocessed bioinks comprised of natural and synthetic polymers for scientific and research use; chemical reagents for scientific purposes, namely, chemical reagents for use in tissue engineering and regenerative medicine research; cell culture media and cell growth supplements for scientific laboratory use; scaffold materials in the nature of chemical preparations for use in biofabrication and tissue engineering for scientific purposes; biological preparations for use in industry and science, namely, extracellular matrix (ECM) compositions for scientific and research use; biological preparations for scientific purposes, namely, collagen and gelatin-based biomaterials for scientific purposes; chemical additives in the nature of chemical substrates and support materials for use in additive manufacturing of biological structures

Filing History

TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 12, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 12, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 12, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 6, 2026 GNRN
NON-FINAL ACTION E-MAILED
Jul 6, 2026 GNRT
NON-FINAL ACTION WRITTEN
Jul 6, 2026 CNRT
ASSIGNED TO EXAMINER
Jun 29, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 28, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Mar 2, 2026 MAFR
NEW APPLICATION ENTERED
Mar 2, 2026 NWAP